C. Damoci

Statistics

Publications

Citations

101

H-Index

Active since

2007

Affiliations

SciClone Pharmaceuticals (United States)(Current)

C. Damoci is an author at SciClone Pharmaceuticals (United States) specializing in molecular oncology, therapeutic antibody development, and therapeutic monoclonal antibodies.

Publications per year

2007–2009

Publications

Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody

Juqun Shen, Marie Danielle Vil, Marie Prewett et al. · Neoplasia · 2009 · 63 citations · Full text

Medicine, Oncology, Pharmacology +16

An antibody directed against PDGF receptor β enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody

Juqun Shen, Marie Danielle Vil, Haifan Zhang et al. · Biochemical and Biophysical Research Communications · 2007 · 38 citations

Medicine, Cancer Biology, Oncology +16

1–2 of 2